INS and type 2 diabetes mellitus: The aim of this real-life study was to collect performance, safety, tolerability and patient’ satisfaction with the A7+TouchCare pump system in patients with T1D and T2D after 3 months of use, in comparison with Omnipod® (Insulet Corp., Bedford, USA), a widespread used insulin patch pump system [7, 15].